The $41 bln parcel carrier is caught in the middle of the U.S.-China trade war; some own goals haven’t helped. The company can manage any hit to its bottom line. But John Foley and Antony Currie explain that any fallout will widen FedEx’s performance g…
AbbVie is buying Allergan, maker of Botox, for $63 billion – a 45% premium. It’s a great deal for the seller’s shareholders, but not much more than an overpriced superficial filler for the buyer. Robert Cyran explains the wrinkles in the merger.
Eldorado Resorts is buying Caesars Entertainment for $8.5 billion. It’s the end of a tawdry financial tale for the indebted Caesars. Upstart Eldorado, meanwhile, is making a big bet it can bring its acquisition and turnaround model to the Las Vegas Str…
The government takeover of a small bank in Inner Mongolia produced surprising ructions in Chinese financial markets. Pete Sweeney and Christopher Beddor discuss what went wrong with Beijing’s plans to let weak lenders default.
Company
The workplace productivity tool landed on the stock market on Thursday, and like many tech listings, it boasts fast-growing revenue, no profit, and stiff competition. Slack’s unusual direct listing method may prove durable even if the company itself do…
Gender pay is a big issue on U.S. proxies this year. Alphabet is fighting a motion to report median male and female salaries, claiming it has equalized pay within job types, but Jen Saba explains that fuller data can help reveal the real problem – a la…
Facebook’s privacy issues make it an unlikely issuer of a cryptocurrency. But as Tom Buerkle explains, Mark Zuckerberg wants to grow the social network’s tiny payments business, and his array of blue-chip partners might encourage consumers to embrace t…
Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.
The Chinese financial centre is bracing for another round of massive protests. Robyn Mak and Pete Sweeney discuss the reasons for the discontent, why the demonstrations caught the government by surprise, and whether Beijing will back down.
The Gallic carmaker may want to restart merger talks with Fiat Chrysler. Potential interference from the French government is still a concern. But as Liam Proud explains, Renault shareholders also need to be more realistic about the takeover value of t…